MORGAN MORGAN: Open Payments
NPI 1548821291 · LINCOLNTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,044 in 401 payments from 23 companies in 2025. Trend: 2023 $4,697 · 2024 $5,317 · 2025 $6,044
Food & beverage: $6,044
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 70 | $1,156 |
| ABBVIE INC. | 102 | $912 |
| Alkermes, Inc. | 23 | $450 |
| Otsuka America Pharmaceutical, Inc. | 35 | $416 |
| Vanda Pharmaceuticals Inc. | 21 | $404 |
| Teva Pharmaceuticals USA, Inc. | 14 | $321 |
| E.R. Squibb & Sons, L.L.C. | 15 | $320 |
| Axsome Therapeutics, Inc. | 16 | $308 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $276 |
| Bausch Health US, LLC | 9 | $199 |
Products named: INGREZZA, VRAYLAR, REXULTI, FANAPT, ARISTADA, COBENFY, Auvelity, CAPLYTA.
Industry payments across NC — which companies pay providers there.
